Martha Shadan
Known title: DirectorCIK: 0001871700
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
LeMaitre Vascular Highlighted as Long-Term Holding Candidate. Recent articles from ChartMill and Yahoo Finance have identified LeMaitre Vascular as a potential long-term holding. These pieces position the medical device maker as a quality stock suitable for investors seeking stability over decades. The commentary reflects a focus on the company's fundamental profile rather than short-term price movements.
Transaction History
| CVRX | ▲ Buy | Grant | 8,720 | $0 | 6/1/2026 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 1 | $0 | 2/26/2026 | View on chart |
| LMAT | ▲ Buy | Grant | 476 | $0 | 2/26/2026 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 5 | $0 | 12/12/2025 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 5 | $0 | 12/12/2025 | View on chart |
| LMAT | ▲ Buy | Grant | 533 | $0 | 12/10/2025 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 2 | $0 | 12/8/2025 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 3 | $0 | 12/8/2025 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 1 | $0 | 12/6/2025 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 1 | $0 | 2/28/2025 | View on chart |
| LMAT | ▲ Buy | Grant | 204 | $0 | 2/28/2025 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 3 | $0 | 12/12/2024 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 3 | $0 | 12/12/2024 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 1 | $0 | 12/9/2024 | View on chart |
| LMAT | ▲ Buy | Grant | 420 | $0 | 12/6/2024 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 1,070 | $50K | 11/13/2024 | View on chart |
| LMAT | ▼ Sell | Open Market | 1,070 | $111K | 11/13/2024 | View on chart |
| LMAT | ▼ Sell | Open Market | 396 | $41K | 11/13/2024 | View on chart |
| LMAT | ▲ Buy | Grant | 593 | $0 | 2/29/2024 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 1 | $0 | 2/29/2024 | View on chart |
| LMAT | ▲ Buy | Option Exercise | 1 | $0 | 12/12/2023 | View on chart |
| LMAT | ▲ Buy | Grant | 512 | $0 | 12/8/2023 | View on chart |
| LMAT | ▲ Buy | Grant | 593 | $0 | 12/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
CVRx Appoints John Landry as CFO
CVRx announced that John Landry will become chief financial officer, effective Oct. 12, replacing Jared Oasheim. The change follows a routine leadership transition and may bring new financial oversight to the company. The appointment is noted by market watchers but does not alter the current trading range or technical signals. Investors can monitor how the new CFO’s approach aligns with the company’s financial goals.
CVRx Appoints John Landry as CFO. CVRx announced that John Landry will become chief financial officer, effective Oct. 12, replacing Jared Oasheim. The change follows a routine leadership transition and may bring new financial oversight to the company. The appointment is noted by market watchers but does not alter the current trading range or technical signals. Investors can monitor how the new CFO’s approach aligns with the company’s financial goals.